Testing of TB vaccine in US

Tribune News Service

Updated At : 11:48 AM May 04, 2020 IST

Unlock Exclusive Insights with The Tribune Premium

Take your experience further with Premium access. Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits

Yearly Premium ₹999 ₹349/Year

Yearly Premium $49 $24.99/Year

Houston, May 3

Researchers in A&M University, Texas, United States, are asking hundreds of frontline medical workers to participate in the late-stage clinical trial of a widely-used tuberculosis vaccine that could help boost the immune system and blunt the devastating effects of Covid-19.

Dr Jeffrey D Cirillo, a Regent’s Professor of Microbial Pathogenesis and Immunology, explained: “Bacillus Calmette–Guérin (BCG) is not meant to cure coronavirus but bridge the gap until a vaccine is developed, thus allowing us to buy time.” — PTI

The Tribune, now published from Chandigarh, started publication on February 2, 1881, in Lahore (now in Pakistan). It was started by Sardar Dyal Singh Majithia, a public-spirited philanthropist, and is run by a trust comprising five eminent persons as trustees.

The Tribune, the largest selling English daily in North India, publishes news and views without any bias or prejudice of any kind. Restraint and moderation, rather than agitational language and partisanship, are the hallmarks of the newspaper. It is an independent newspaper in the real sense of the term.

The Tribune has two sister publications, Punjabi Tribune (in Punjabi) and Dainik Tribune (in Hindi).

Remembering Sardar Dyal Singh Majithia

Designed and developed by : SORTD

Unlock Exclusive Insights with The Tribune Premium

Suggested Articles